-

JLL Partners Announces Hiring of Jeff Hunter as Chief AI Officer

NEW YORK--(BUSINESS WIRE)--JLL Partners, LLC (“JLL” or “the Firm”), a New York-based middle market private equity firm focused on investing in businesses in the healthcare, aerospace and defense, and business services sectors, today announced that Jeff Hunter has joined the Firm as Chief AI Officer.

Mr. Hunter will oversee the AI function at JLL and lead the Firm’s efforts to effectively utilize and leverage artificial intelligence and new technology solutions to help drive continued growth. Mr. Hunter was most recently a Senior Managing Director at Ankura, a litigation consulting firm, where he focused on improving the firm's use of AI while prototyping and launching client-facing, revenue-generating products. Prior to Ankura, he held senior leadership positions at Capgemini and PwC, as Chief Data Scientist and founder of the Data Science Center of Excellence, respectively. Earlier in his career, he served under Ross Perot at Perot Systems before joining Booz Allen where he became a recognized cyber security and intelligence expert.

"Jeff's deep knowledge and proven track record in developing cutting-edge AI solutions will be instrumental in driving competitive advantage and risk mitigation in our portfolio,” said Dan Agroskin, a Managing Partner at JLL. "We are excited to welcome Jeff to our team and look forward to the strategic value he will bring to JLL as we continue to thoughtfully scale our platform.”

Mr. Hunter holds a bachelor's degree in Computational Cognitive Psychology from George Mason University and an MBA with a Finance and Risk Modeling concentration from Duke Fuqua School of Business.

About JLL Partners

JLL Partners, LLC is a middle market private equity firm with over three decades of experience transforming businesses in the healthcare, aerospace and defense, and business services sectors. The Firm is dedicated to partnering with companies that it believes it can help build into market leaders through a combination of strategic mergers and acquisitions, organic growth initiatives, and operational enhancements. The JLL Partners team is comprised of seasoned investment professionals and operating partners who are focused on driving long-term value creation across its portfolio. Since its founding in 1988, JLL Partners has invested approximately $8 billion of equity capital across nine private equity funds, with 60 platform investments and more than 187 add-on acquisitions.

For additional information, please visit www.jllpartners.com.

Contacts

Eli Kapsack
Profile Advisors
ekapsack@profileadvisors.com

JLL Partners, LLC


Release Versions

Contacts

Eli Kapsack
Profile Advisors
ekapsack@profileadvisors.com

More News From JLL Partners, LLC

JLL Partners Announces Combination of Vascular Technology Incorporated and Parks Medical Electronics

NEW YORK--(BUSINESS WIRE)--JLL Partners (“JLL” or the “Firm”), a New York-based middle market private equity firm focused on investing in the healthcare, aerospace and defense, and business services sectors, today announced its acquisition of Parks Medical Electronics (“Parks” or the “Company”), a leading manufacturer of medical Doppler ultrasound systems for use in hospital, clinic, and veterinary settings, and the Flo-Lab Vascular system, a diagnostic tool used to evaluate blood flow in patie...

Maggie Anderson Joins JLL Partners as an Operating Partner

NEW YORK--(BUSINESS WIRE)--JLL Partners, LLC (“JLL” or the “Firm”), a New York-based middle market private equity firm focused on investing in businesses in the healthcare, aerospace and defense, and business services sectors, today announced that Maggie Anderson has joined the Firm as an Operating Partner. Ms. Anderson possesses more than 25 years of collective experience in healthcare, private equity, and management consulting. Prior to joining JLL Ms. Anderson was an SVP at DaVita, a global...

JLL Partners Announces Investment in Vascular Technology, Incorporated

NEW YORK--(BUSINESS WIRE)--JLL Partners (“JLL” or the “Firm”), a New York-based middle market private equity firm focused on investing in the healthcare, aerospace and defense, and business services sectors, today announced its investment in Vascular Technology, Incorporated (“VTI” or the “Company”), a medical device company specializing in innovative surgical devices and single-use consumables for the operating room. Through this transaction, JLL partnered with entrepreneur Nilendu Srivastava...
Back to Newsroom